Research ExplorerScientific StaffSarah Jane Pauline Minner Publications

Dr. ID: 40302

Sarah Jane Pauline Minner

graph of relations
Affiliations
151 - 200 out of 207Page size: 50

Publications

  1. 2014

  2. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer

    Krohn, A., Freudenthaler, F., Harasimowicz, S., Kluth, M., Fuchs, S., Burkhardt, L., Stahl, P., C Tsourlakis, M., Bauer, M., Tennstedt, P., Graefen, M., Steurer, S., Sirma, H., Sauter, G., Schlomm, T., Simon, R. & Minner, S., 25.04.2014, In: MODERN PATHOL. 27, 12, p. 1612-1620

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Reduced membranous MET expression is linked to bladder cancer progression

    Kluth, M., Reynolds, K., Rink, M., Chun, F., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Doh, O., Terracciano, L., Simon, R., Sauter, G. & Minner, S., 01.04.2014, In: CANCER GENET-NY. 207, 4, p. 147-52 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Gender-specific outcomes of bladder cancer patients: A stage-specific analysis in a contemporary, homogenous radical cystectomy cohort

    Soave, A., Dahlem, R., Hansen, J., Weisbach, L., Minner, S., Engel, O., Kluth, L. A., Chun, F. K., Shariat, S. F., Fisch, M. & Rink, M., 13.03.2014, In: EJSO-EUR J SURG ONC. 41, 3, p. 368-377

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice

    Burandt, E., Schreiber, M., Stein, A., Minner, S., Clauditz, T. S., Bokemeyer, C., Jänicke, F., Fisch, M., Izbicki, J. R., Knecht, R., Sauter, G. & Stahl, P. R., 01.03.2014, In: GENE CHROMOSOME CANC. 53, 3, p. 228-39 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions

    Grupp, K., Wilking, J., Prien, K., Hube-Magg, C., Sirma, H., Simon, R., Steurer, S., Budäus, L., Haese, A., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.03.2014, In: EUR J CANCER. 50, 4, p. 852-61 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion

    Tsourlakis, M. C., Weigand, P., Grupp, K., Kluth, M., Steurer, S., Schlomm, T., Graefen, M., Huland, H., Salomon, G., Steuber, T., Wilczak, W., Sirma, H., Simon, R., Sauter, G., Minner, S. & Quaas, A., 01.03.2014, In: AM J PATHOL. 184, 3, p. 609-17 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

    Kluth, M., Harasimowicz, S., Burkhardt, L., Grupp, K., Krohn, A., Prien, K., Gjoni, J., Hass, T., Galal, R., Graefen, M., Haese, A., Simon, R., Hühne-Simon, J., Koop, C., Korbel, J., Weischenfeld, J., Huland, H., Sauter, G., Quaas, A., Wilczak, W., Tsourlakis, M. C., Minner, S. & Schlomm, T., 13.02.2014, In: INT J CANCER. 135, 6, p. 1369-1380

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  9. A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy

    Adam, M., Hannah, A., Budäus, L., Steuber, T., Salomon, G., Michl, U., Haese, A., Fisch, M., Wittmer, C., Steurer, S., Minner, S., Heinzer, H., Huland, H., Graefen, M., Sauter, G., Schlomm, T. & Isbarn, H., 08.02.2014, In: J UROLOGY. 192, 1, p. 97-101

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR

    Tennstedt, P., Bölch, C., Strobel, G., Minner, S., Burkhardt, L., Grob, T., Masser, S., Sauter, G., Schlomm, T. & Simon, R., 01.02.2014, In: INT J ONCOL. 44, 2, p. 609-15 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

    Grupp, K., Habermann, M., Sirma, H., Simon, R., Steurer, S., Hube-Magg, C., Prien, K., Burkhardt, L., Jedrzejewska, K., Salomon, G., Heinzer, H., Wilczak, W., Kluth, M., Izbicki, J. R., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.01.2014, In: MODERN PATHOL. 27, 1, p. 96-106 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse

    Hennigs, J. K., Müller, J., Adam, M., Spin, J. M., Riedel, E., Graefen, M., Bokemeyer, C., Sauter, G., Huland, H., Schlomm, T. & Minner, S., 01.01.2014, In: PLOS ONE. 9, 7, p. e100469

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2013

  14. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

    Grupp, K., Sanader, S., Sirma, H., Simon, R., Koop, C., Prien, K., Hube-Magg, C., Salomon, G., Graefen, M., Heinzer, H., Minner, S., Izbicki, J. R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 01.12.2013, In: MOL ONCOL. 7, 6, p. 1001-11 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

    Sirma, H., Broemel, M., Stumm, L., Tsourlakis, M. C., Steurer, S., Tennstedt, P., Salomon, G., Michl, U., Haese, A., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 01.11.2013, In: ONCOL LETT. 6, 5, p. 1245-1252 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer

    Cordes, I., Kluth, M., Zygis, D., Rink, M., Chun, F., Eichelberg, C., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Doh, O., Terracciano, L., Simon, R., Wilczak, W., Sauter, G. & Minner, S., 01.11.2013, In: HISTOPATHOLOGY. 63, 5, p. 670-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

    Grupp, K., Diebel, F., Sirma, H., Simon, R., Breitmeyer, K., Steurer, S., Hube-Magg, C., Prien, K., Pham, T., Weigand, P., Michl, U., Heinzer, H., Kluth, M., Minner, S., Tsourlakis, M. C., Izbicki, J. R., Sauter, G., Schlomm, T. & Wilczak, W., 01.11.2013, In: PROSTATE. 73, 15, p. 1690-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer

    Quaas, A., Bahar, A. S., Loga, K., Seddiqi, A. S., Singer, J. M., Omidi, M., Kraus, O., Kwiatkowski, M., Trusch, M., Minner, S., Burandt, E., Stahl, P., Wilczak, W., Wurlitzer, M., Simon, R., Sauter, G., Marx, A. & Schlüter, H., 01.10.2013, In: HISTOPATHOLOGY. 63, 4, p. 455-62 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    Grupp, K., Höhne, T. S., Prien, K., Hube-Magg, C., Tsourlakis, M. C., Sirma, H., Pham, T., Heinzer, H., Graefen, M., Michl, U., Simon, R., Wilczak, W., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Steurer, S., 01.10.2013, In: EXP MOL PATHOL. 95, 2, p. 227-34 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

    Tsourlakis, M. C., Schoop, M., Plaß, C., Huland, H., Graefen, M., Steuber, T., Schlomm, T., Simon, R., Sauter, G., Sirma, H. & Minner, S., 01.09.2013, In: HUM PATHOL. 44, 9, p. 1789-96 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

    Krohn, A., Seidel, A., Burkhardt, L., Bachmann, F., Mader, M., Grupp, K., Eichenauer, T., Becker, A., Adam, M., Graefen, M., Huland, H., Kurtz, S., Steurer, S., Tsourlakis, M. C., Minner, S., Michl, U., Schlomm, T., Sauter, G., Simon, R. & Sirma, H., 01.09.2013, In: AM J PATHOL. 231, 1, p. 130-41 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells

    Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T. & Mills, I. G., 15.08.2013, In: CANCER RES. 73, 16, p. 5277-87 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells

    Kobold, S., Völk, S., Clauditz, T., Küpper, N. J., Minner, S., Tufman, A., Düwell, P., Lindner, M., Koch, I., Heidegger, S., Rothenfuer, S., Schnurr, M., Huber, R. M., Wilczak, W. & Endres, S., 01.08.2013, In: J THORAC ONCOL. 8, 8, p. 1032-42 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

    Kluth, M., Hesse, J., Heinl, A., Krohn, A., Steurer, S., Sirma, H., Simon, R., Mayer, P-S., Schumacher, U., Grupp, K., Izbicki, J. R., Pantel, K., Dikomey, E., Korbel, J. O., Plass, C., Sauter, G., Schlomm, T. & Minner, S., 01.07.2013, In: MODERN PATHOL. 26, 7, p. 975-83 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer

    Gannon, P. O., Lessard, L., Stevens, L-M., Forest, V., Bégin, L. R., Minner, S., Tennstedt, P., Schlomm, T., Mes-Masson, A-M. & Saad, F., 01.07.2013, In: EUR J CANCER. 49, 10, p. 2441-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy

    Tsourlakis, M. C., Delmo Walter, E. M., Quaas, A., Graefen, M., Huland, H., Simon, R., Sauter, G., Steurer, S., Schlomm, T. & Minner, S., 01.06.2013, In: PROSTATE CANCER P D. 16, 2, p. 159-64 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

    Burkhardt, L., Fuchs, S., Krohn, A., Masser, S., Mader, M., Kluth, M., Bachmann, F., Huland, H., Steuber, T., Graefen, M., Schlomm, T., Minner, S., Sauter, G., Sirma, H. & Simon, R., 01.05.2013, In: CANCER RES. 73, 9, p. 2795-805 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

    Flammiger, A., Weisbach, L., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 01.04.2013, In: EUR J CANCER. 49, 6, p. 1273-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. High mitochondria content is associated with prostate cancer disease progression

    Grupp, K., Jedrzejewska, K., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Quaas, A., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Schlomm, T., Minner, S. & Steurer, S., 01.01.2013, In: MOL CANCER. 12, 1, p. 145

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

    Grupp, K., Kohl, S., Sirma, H., Simon, R., Steurer, S., Becker, A., Adam, M., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 2013, In: MODERN PATHOL. 26, 5, p. 733-742 10 p., 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma.

    Eichelberg, C., Chun, F., Bedke, J., Heuer, R., Adam, M., Moch, H., Terracciano, L., Hinrichs, K., Dahlem, R., Fisch, M., Schlomm, T., Sauter, G. & Minner, S. J. P., 2013, In: INT J CANCER. 132, 12, p. 2948-2955 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

    Jacobsen, F., Ashtiani, S. N., Tennstedt, P., Heinzer, H., Simon, R., Sauter, G., Sirma, H., Tsourlakis, M. C., Minner, S. J. P., Schlomm, T. & Michl, U., 2013, In: EXP THER MED. 5, 1, p. 102-106 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

    Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H-J., Stehr, H., Rausch, T., Jäger, N., Gu, L., Bogatyrova, O., Stütz, A. M., Claus, R., Eils, J., Eils, R., Gerhäuser, C., Huang, P-H., Hutter, B., Kabbe, R., Lawerenz, C., Radomski, S., Bartholomae, C. C., Fälth, M., Gade, S., Schmidt, M., Amschler, N., Hass, T., Galal, R., Gjoni, J., Kuner, R., Baer, C., Masser, S., von Kalle, C., Zichner, T., Benes, V., Raeder, B., Mader, M., Amstislavskiy, V., Avci, M., Lehrach, H., Parkhomchuk, D., Sultan, M., Burkhardt, L., Graefen, M., Huland, H., Kluth, M., Krohn, A., Sirma, H., Stumm, L., Steurer, S., Grupp, K., Sültmann, H., Sauter, G., Plass, C., Brors, B., Yaspo, M-L., Korbel, J. O. & Schlomm, T., 2013, In: CANCER CELL. 23, 2, p. 159-170 12 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

    Müller, J., Ehlers, A., Burkhardt, L., Sirma, H., Steuber, T., Graefen, M., Sauter, G., Minner, S. J. P., Simon, R., Schlomm, T. & Michl, U., 2013, In: INT J CANCER. 132, 6, p. 1333-1340 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

    Steurer, S., Borkowski, C., Odinga, S., Buchholz, M., Koop, C., Huland, H., Becker, M., Witt, M., Trede, D., Omidi, M., Kraus, O., Bahar, A. S., Seddiqi, A. S., Singer, J. M., Kwiatkowski, M., Trusch, M., Simon, R., Wurlitzer, M., Minner, S., Schlomm, T., Sauter, G. & Schlüter, H., 2013, In: INT J CANCER. 133, 4, p. 920-928 9 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Marked heterogeneity of ERG expression in large primary prostate cancers.

    Minner, S., Gärtner, M., Freudenthaler, F., Bauer, M., Kluth, M., Salomon, G., Heinzer, H., Graefen, M., Bokemeyer, C., Simon, R., Sauter, G., Schlomm, T. & Wilczak, W., 2013, In: MODERN PATHOL. 26, 1, p. 106-116 11 p., 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

    Eichelberg, C., Minner, S., Isbarn, H., Burandt, E., Terracciano, L., Moch, H., Kell, A., Heuer, R., Chun, F. K., Sauter, G., Fisch, M. & Tennstedt, P., 2013, In: WORLD J UROL. 31, 4, p. 847-53 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

    Stumm, L., Burkhardt, L., Steurer, S., Simon, R., Adam, M., Becker, A., Sauter, G., Minner, S., Schlomm, T., Sirma, H. & Michl, U., 2013, In: J CLIN PATHOL. 66, 7, p. 563-568 6 p., 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. 2012

  40. Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

    Flammiger, A., Bayer, F., Cirugeda-Kühnert, A., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 11.2012, In: APMIS. 120, 11, p. 901-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.

    Minner, S. J. P., Lübke, A., Kluth, M., Bokemeyer, C., Jänicke, F., Izbicki, J. R., Schlomm, T., Sauter, G. & Wilczak, W., 01.09.2012, In: HISTOPATHOLOGY. 61, 3, p. 445-453 9 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

    Minner, S. J. P., De Silva, C., Rink, M., Dahlem, R., Chun, F., Fisch, M., Höppner, W., Wagner, W., Bokemeyer, C., Terracciano, L., Simon, R., Sauter, G. & Wilczak, W., 08.2012, In: PATHOLOGY. 44, 5, p. 448-452 5 p., 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients

    Tachezy, M., Harms-Effenberger, K., Zander, H., Minner, S. J. P., Gebauer, F., Vashist, Y., Sauter, G., Pantel, K., Izbicki, J. R. & Bockhorn, M., 15.07.2012, In: INT J CANCER. 131, 2, p. 396-405 10 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.

    Krohn, A., Diedler, T., Burkhardt, L., Mayer, P. S., Colin, D. S., Meyer-Kornblum, M., Kötschau, D., Tennstedt, P., Huang, J., Gerhäuser, C., Mader, M., Kurtz, S., Sirma, H., Saad, F., Steuber, T., Graefen, M., Plass, C., Sauter, G., Simon, R., Minner, S. J. P. & Schlomm, T., 2012, In: AM J PATHOL. 181, 2, p. 401-412 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.

    Schlomm, T., Tennstedt, P., Huxhold, C., Steuber, T., Salomon, G., Michl, U., Heinzer, H., Hansen, J., Budäus, L., Steurer, S., Wittmer, C., Minner, S. J. P., Haese, A., Sauter, G., Graefen, M. & Huland, H., 2012, In: EUR UROL. 62, 2, p. 333-340 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.

    Rink, M., Chun, F., Dahlem, R., Soave, A., Minner, S. J. P., Hansen, J., Stoupiec, M., Coith, C., Kluth, L., Ahyai, S., Friedrich, M. G., Shariat, S. F., Fisch, M., Pantel, K. & Riethdorf, S., 2012, In: EUR UROL. 61, 4, p. 810-817 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

    Stahl, P., Kilgué, A., Tennstedt, P., Minner, S. J. P., Krohn, A., Simon, R., Krause, G., Izbicki, J. R., Graefen, M., Sauter, G., Schlomm, T. & Wilczak, W., 2012, In: PROSTATE. 72, 8, p. 898-903 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 2011

  49. Older patients suffer from adverse histopathological features after radical cystectomy

    Rink, M., Dahlem, R., Kluth, L., Minner, S., Ahyai, S. A., Eichelberg, C., Fisch, M. & Chun, F. K., 08.2011, In: INT J UROL. 18, 8, p. 576-84 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.

    Rink, M., Chun, F., Minner, S. J. P., Friedrich, M., Mauermann, O., Heinzer, H., Huland, H., Fisch, M., Pantel, K. & Riethdorf, S., 2011, In: BJU INT. 107, 10, p. 1668-1675 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

    Minner, S. J. P., Enodien, M., Sirma, H., Lübke, A., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., Brase, J. C., Liu, A. Y., Schlüter, H., Pantel, K., Schumacher, U., Bokemeyer, C., Steuber, T., Graefen, M., Sauter, G. & Schlomm, T., 2011, In: CLIN CANCER RES. 17, 18, p. 5878-5888 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

    Minner, S. J. P., Wittmer, C., Graefen, M., Salomon, G., Steuber, T., Haese, A., Huland, H., Bokemeyer, C., Yekebas, E. F., Dierlamm, J., Balabanov, S., Kilic, E., Wilczak, W., Simon, R., Sauter, G. & Schlomm, T., 2011, In: PROSTATE. 71, 3, p. 281-288 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

    Minner, S. J. P., Kraetzig, F., Tachezy, M., Kilic, E., Graefen, M., Wilczak, W., Bokemeyer, C., Huland, H., Sauter, G. & Schlomm, T., 2011, In: HUM PATHOL. 42, 12, p. 1946-1952 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.

    Stieler, K., Schindler, S., Schlomm, T., Hohn, O., Bannert, N., Simon, R., Minner, S. J. P., Schindler, M. & Fischer, N., 2011, In: PLOS ONE. 6, 10, p. 25592 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next